Treatment Approach for Shoulder Pain with Mild Glenohumeral Osteoarthritis
Begin with conservative management consisting of physical therapy and NSAIDs as first-line treatment for this patient's mild degenerative glenohumeral joint changes. 1
Immediate Clinical Actions
Address the Scapular Cortical Irregularity
- Obtain CT imaging of the scapula if clinical suspicion for acute fracture exists, as the radiologist notes this finding is only visible on one view and cannot exclude acute fracture. 2
- If CT confirms no acute fracture and the irregularity represents old trauma or normal variant, proceed with conservative management for the degenerative changes. 2
Incidental Calcified Granuloma
- The 6 mm perihilar calcification stable from prior imaging requires no acute intervention, as it likely represents a benign calcified granuloma. 2
- No further pulmonary workup is needed for stable calcified granulomas.
Conservative Treatment Protocol
Physical Therapy (First-Line)
Physical therapy should target three specific goals for glenohumeral OA: 3
- Pain reduction: Most effective for motion-related pain rather than rest pain. 3
- ROM improvement: Identify and target specific soft tissue restrictions limiting shoulder motion. 3
- Joint protection: Implement rotator cuff strengthening exercises to stabilize the glenohumeral joint. 3
- Address abnormal scapular motion patterns that develop as compensation for restricted glenohumeral movement. 3
Pharmacological Management
NSAIDs are recommended as first-line pharmacological therapy per NICE guidelines, though evidence is extrapolated from hip and knee OA literature rather than shoulder-specific studies. 1, 4
- Oral NSAIDs provide pain relief and reduce joint inflammation, enabling more effective physical therapy participation. 3, 4
- Topical NSAIDs can be considered as alternatives. 4
- Acetaminophen may be used for pain control. 4
- Vitamin C and D supplementation may slow cartilage degeneration. 3
Injectable Options (If Conservative Measures Fail)
Corticosteroid injections have insufficient evidence to recommend for or against use (Grade I recommendation), but may provide longer-term symptom relief in refractory cases. 1
Viscosupplementation (hyaluronic acid) is a treatment option with weak supporting evidence (Grade C recommendation). 1
- Biologics (platelet-rich plasma, bone marrow aspirate concentrate, mesenchymal stem cells) may decrease pain but do not stop OA progression or improve underlying disease. 3
- Limited evidence exists for biologics, requiring cautious use. 3, 4
When to Consider Surgical Intervention
Surgery is reserved for severe or refractory cases when conservative management fails after adequate trial (typically several months). 5
Total shoulder arthroplasty (TSA) is preferred over hemiarthroplasty for advanced glenohumeral OA, providing superior pain relief and clinical outcomes with moderate-strength evidence (Grade B recommendation). 1
Surgical Contraindications and Considerations
- Avoid TSA in patients with irreparable rotator cuff tears; consider reverse total shoulder arthroplasty instead. 1
- Delay arthroplasty in patients <50 years when possible due to increased prosthetic loosening risk and decreased survivorship. 1
- Pre-operative imaging must evaluate glenoid morphology, bone loss, retroversion, and bone quality. 1
Common Pitfalls to Avoid
- Do not attempt reduction without proper imaging if dislocation is suspected, as this could worsen fracture-dislocations. 2
- Most treatment recommendations are extrapolated from hip/knee literature rather than shoulder-specific studies, requiring clinical judgment. 1
- Physical therapy lacks high-quality evidence for glenohumeral OA specifically, but remains standard practice. 1
- Shoulder arthroplasty complications occur in up to 39.8% of cases with revision rates up to 11%. 1
Clinical Algorithm Summary
- Obtain CT of scapula if acute fracture cannot be excluded clinically
- Initiate physical therapy targeting pain, ROM, and rotator cuff strengthening
- Start oral NSAIDs for pain and inflammation control
- Consider corticosteroid or hyaluronic acid injections if conservative measures fail after 3-6 months
- Refer for surgical evaluation only if symptoms remain debilitating despite exhaustive conservative treatment